Differentially expressed genes were identified by RNA-seq, sequencing was carried on in biological duplicates and hits filtered for FDR < 0.05, yielding 8,295,863 and 106,747,280 reads for the scramble transfected control, and 8,177,967 and 21,921,280 for the antimiR-9 transfected cells. 72% and 51% reads mapped to the scrambled treated duplicates, and 73% and 60% mapped to the antimiR-9 treated duplicates. Supplementary Fig.1a--b: a) The efficiency and specificity of miR-9 inhibition antimiR-9 #1 and #3 (an 8-mer and a full-length antimiR-9) was checked by co-transfection of a luciferase reporter containing 2X perfect match miR-9 binding sites. b) U87MG were transfected with a miR--9 mimic, a miR--9 mimic labeled with biotin or a miR--9 mimic labeled with biotin and containing thiouridin. qPCR was used to measure MALAT1 enrichment in the pull--out samples over the inputs. The p value was calculated by ANOVA b) qPCR shows that up-regulation of MALAT1 following miR-9 inhibition in L428, can still be detected by using a full length (antimiR-9 #3) or a 15-mer (antimiR-9 #2) antimiR-9. Bars show mean +/-SD. b) qPCR shows down-regulation of MALAT1 following miR-9 overexpression in two different cell lines. p-values were calculated by t-test. Bars show mean +/-SEM (n=3).
Supplementary Fig.3:
Cells were transfected with two different constructs encoding luciferase activity under control of miR-9 binding sites (position 6229 and position 1199 respectively) in MALAT1 sequence, alone, in presence of a antimiR-9 or a scrambled control oligonucleotide.
antimiR-9 induces an increase in luciferase activity. p-values were calculated by twoways ANOVA. Bars show mean +/-SEM (n=3) Supplementary Fig. 4a-b: a) Nuclear and cytoplasmic fractions were isolated from L428 transfected with a scramble control or an antimiR-9, and immunoprecipitated using AGO2 antibody. The western blot shows the purity of the extracts and the efficiency of AGO2
immunoprecipitation. The signal for tubulin in the nuclei is the result of a cross-reaction of the antibody with the Immunoglobulin.
b) The amount of MALAT1 bound to AGO2 was measured by qPCR in nuclear and cytoplasmic fractions in presence of a scrambled control or an antimiR-9. Bars show mean +/-SEM (n=3). p-values were calculated by two-ways ANOVA.
Supplementary figure 5:
MALAT1 inhibition did not affect miR-9 expression. Levels of MALAT1 (relative to HPRT) and miR-9 (relative to RNU6B) were measured by qPCR in L428 upon inhibition of miR-9 only, MALAT1 only or a combination of the two. Error bars represent standard deviations. 
